RocheJapanese subsidiary Chugai Pharmaceutical has established an antibody subsidiary in Singapore. Chugai Pharmabody Research Pte. Ltd is tasked with developing antibody drug candidates more quickly and efficiently. To enrich its research pipeline, Chugai has set an annual goal of five new candidates for the new entity. The new site is also part of Chugai’s research network; Chugai has previously established research collaborations with three other centers in Asia, in South Korea, Pharmaceuticals Research in Singapore, and Forerunner Pharma Research Co. in Tokyo. (Click here for more – Japanese language
)
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?